Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
Translational Andrology and Urology|July 28, 2018
Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapyFei Yang, John C Ford, Nesrin Dogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10Rile Li, Kateri Heydon, M Elizabeth Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2011
Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancerNiraj Pahlajani, Karen J Ruth, Mark K Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancerDavid J D'Ambrosio, Alexandra L Hanlon, Tahseen Al-Saleem, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 31, 2020
Margin verification for hypofractionated prostate radiotherapy using a novel dose accumulation workflow and iterative CBCTMatthew T Studenski, Rodrigo Delgadillo, Yihang Xu, et al.
Cancers|May 16, 2023
Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep LearningRyan Fogarty, Dmitry Goldgof, Lawrence Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort StudyThomas Eade, Ananya Choudhury, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implantThomas N Eade, Eric M Horwitz, Karen Ruth, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialAlan Pollack, Gunar K Zagars, George Starkschall, et al.
Cancer|July 12, 2005
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610Li-Yan Khor, Michelle Desilvio, Tahseen Al-Saleem, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
Translational Andrology and Urology|July 28, 2018
Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapyFei Yang, John C Ford, Nesrin Dogan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10Rile Li, Kateri Heydon, M Elizabeth Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2011
Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancerNiraj Pahlajani, Karen J Ruth, Mark K Buyyounouski, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancerDavid J D'Ambrosio, Alexandra L Hanlon, Tahseen Al-Saleem, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 31, 2020
Margin verification for hypofractionated prostate radiotherapy using a novel dose accumulation workflow and iterative CBCTMatthew T Studenski, Rodrigo Delgadillo, Yihang Xu, et al.
Cancers|May 16, 2023
Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep LearningRyan Fogarty, Dmitry Goldgof, Lawrence Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort StudyThomas Eade, Ananya Choudhury, Alan Pollack, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implantThomas N Eade, Eric M Horwitz, Karen Ruth, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trialAlan Pollack, Gunar K Zagars, George Starkschall, et al.
Cancer|July 12, 2005
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610Li-Yan Khor, Michelle Desilvio, Tahseen Al-Saleem, et al.
Pageof 27